Raleigh, NC, December 14, 2023—Veranex, provider of the first purpose-built, global service platform for the medtech industry, today announced that it has acquired T3 Labs, a highly reputable preclinical laboratory located in Atlanta, Georgia. This acquisition...
Opportunity Ahead in the Cardiovascular Devices Market
Get a comprehensive analysis of the cardiovascular devices market including its current state and emerging opportunities from a panel of experts including moderation from Robert Kieval, EVP of Strategic Partnerships at Veranex.
Preclinical Insights #39 — 25 Years of Preclinical Paris: A Conversation with Our Founders
Veranex is proud to share the latest issue of our Preclinical Insights publication. In this issue we talk with Preclinical Paris Founders Nicolas Borenstein and Luc Behr on the changes they've experienced over the past 25 years, the legacy they've created, and trends...